Search - tctmd.com

Displaying 481 - 500 of 900

Sort: Relevancy | Date

Presentation

Use and Outcomes of Triple Therapy Among Older Patients With Acute MI and A-fib

Presenter: Connie N. Hess

August 03, 2015

Presentation

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Presenter: K. Tsujita

July 28, 2015

Presentation SCCT 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presenter: Maros Ferencik

July 18, 2015

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

Presentation

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Presenter: Charles V. Pollack Jr

June 24, 2015

Presentation

Endovascular Therapy for Acute Ischemic Stroke

Presenter: Partha Sardar

June 22, 2015

Presentation

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Presenter: P. Widimsky

June 19, 2015

Presentation CCVVC 2015

Top 10 Advances of Interventional Cardiology 2014

Presenter: Samin K Sharma

June 17, 2015

Presentation CCVVC 2015

Data for Recent Antiplatelets and Antithrombotics

Presenter: Deepak L. Bhatt

June 17, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Bivalirudin Is Associated With Improved Clinical and Economic Outcomes in HF Patients Undergoing PCI

Presenter: DS. Pinto

June 08, 2015

Presentation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Presenter: Ying Xian

May 27, 2015

Presentation Fellows 2015

Case 2

Presenter: Roxana Mehran, David J. Cohen, Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Presenter: Usman Baber

May 11, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

Presentation

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Presenter: Gregory Ducrocq

April 24, 2015

Advertisement

Use and Outcomes of Triple Therapy Among Older Patients With Acute MI and A-fib

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Endovascular Therapy for Acute Ischemic Stroke

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Top 10 Advances of Interventional Cardiology 2014

Data for Recent Antiplatelets and Antithrombotics

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Bivalirudin Is Associated With Improved Clinical and Economic Outcomes in HF Patients Undergoing PCI

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Case 2

Case 1

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Antiplatelet Therapy for the Interventionalist

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content